News

Egiss is listed as a Representative Vendor in the 2026 GartnerĀ® Market Guide for Managed Device Life Cycle Services.

Get complimentary access
Pharma

Technology lifecycle control for regulated global environments.

Egiss helps pharma and life sciences enterprises deploy, manage and retire technology across countries through one global standard, local execution and documented lifecycle governance.

Named customer proof includes Novo Nordisk and other global enterprises.

Pharma technology decisions carry operational, compliance and documentation weight.

Pharma organisations operate across research, production, commercial, office, field and regulated environments. Technology needs to be available and consistent, but also governed, documented and retired responsibly.

When procurement, deployment, asset visibility and ITAD vary by country, global teams can lose control over standards, evidence, risk and reporting.

Common challenges

Where pharma lifecycle models come under pressure.

  • Technology standards vary across countries, sites and business units.
  • Local suppliers create inconsistent catalogues and documentation.
  • Delivery, provisioning and replacement processes are hard to compare globally.
  • Asset visibility is incomplete across distributed environments.
  • Security and compliance teams need stronger chain-of-custody evidence.
  • ITAD and data sanitisation documentation varies by market.
  • Sustainability reporting needs reliable recovery and recycling data.
  • Procurement needs commercial control without slowing local execution.
  • Regional teams need a model that works with existing systems and governance.

The Egiss approach

Connect lifecycle execution to governance and evidence.

Egiss helps pharma enterprises connect technology sourcing, deployment, lifecycle visibility, ITAD, sustainability reporting and contractual accountability through one global operating model.

  1. Deploy

    Source, configure, provision and deliver technology consistently across approved standards.

  2. Manage

    Support lifecycle visibility, reporting, integrations, stock, service coordination and governance.

  3. Retire

    Recover, sanitise, document, refurbish, remarket, recycle and report on used assets.

Technology areas in scope

Support for the technology categories around global pharma operations.

  • Workplace technology

    End-user devices, mobility, accessories and workplace equipment for office, commercial, field and support teams.

  • Operational technology

    Frontline, site, logistics and operational equipment where replacement discipline and local execution matter.

  • Infrastructure technology

    Servers, storage, networking and related infrastructure sourced through a governed global model.

  • IT asset disposition

    Secure recovery, data sanitisation, chain-of-custody documentation, refurbishment, remarketing, recycling and reporting.

  • Sustainability and circularity

    Reporting inputs for reuse, recovery value, recycling and environmental impact where scope and methodology are agreed.

Buyer committee value

Pharma buyers need consistency, evidence and accountability.

  • Procurement

    Create clearer supplier governance, commercial logic and contract accountability across countries.

  • CIO and digital workplace

    Support global standards, user readiness and scalable lifecycle execution.

  • IT operations

    Reduce country-level escalation effort and improve visibility into delivery and lifecycle status.

  • Security and compliance

    Strengthen data sanitisation evidence, chain of custody and audit-ready retirement documentation.

  • ESG

    Connect ITAD, recovery, reuse, recycling and sustainability reporting to lifecycle data.

  • Finance

    Improve visibility into lifecycle cost, stock, replacement timing and residual value.

Regulated buyers need proof they can inspect.

  • ISO 9001, 14001, 27001 & 45001Certificate scope documented for the relevant service
  • EcoVadis GoldSustainability rating
  • 180+ countriesGlobal delivery with local execution
  • 98% on-time deliveryMeasured execution performance
  • +79 NPSCustomer experience measured at scale
  • Blue Stripe GuaranteePrice, quality and delivery as expected
  • Contractual penaltiesA standard part of Egiss contracts
  • Novo NordiskPublic customer reference

Frequently asked questions

Can your technology lifecycle stand up to pharma governance requirements?

Egiss can help review your current model across sourcing, deployment, reporting, ITAD, sustainability documentation and lifecycle accountability.